Saxenda, Wegovy, Ozempic, and Mounjaro are all GLP-1 receptor agonists that assist type 2 diabetics and aid in weight loss. Patients are told to take these medications in conjunction with a reduced calorie diet and an increase in physical activity. Although they all contain GLP-1 receptor agonists, there are differences in terms of their formulations, doses, costs, and what they are FDA approved for.